Collaboration is one of PQA's greatest attributes, and our measure development process embodies how our diverse member organizations reach consensus on evaluating medication use quality. The public comment period is an important part of our systematic and transparent consensus-based process.
The upcoming 2024 PQA Annual Meeting's poster session will showcase 23 quality improvement and research projects. Sponsored by Pharmacy Quality Solutions, this session offers authors a platform to exhibit their work and enables attendees to engage in insightful discussions about healthcare quality.
Have you made your plans to attend the 2024 PQA Annual Meeting? This year's meeting will be held in Baltimore from May 14 -16. Early registration ends Friday, April 19; register today to take advantage of the member discount!
The 2024 PQA Annual Meeting is less than six weeks away, and we are excited to welcome you all back to Baltimore!
PQA is a non-profit organization with 250 diverse members across healthcare. Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
Today is an exciting and important day for PQA. The PQA Board of Directors completed the sale of all of PQA’s shares in Pharmacy Quality Solutions (PQS) to Innovaccer, a San Francisco, CA based healthcare technology company with a platform unifying patient data across systems and care settings. A statement from our Board Chair, Susan Cantrell, followed the Innovaccer’s announcement at the HIMSS Global Health Conference & Exhibition in Orlando.
Have you made your plans to join us at the 2024 PQA Annual Meeting, May 14-16, in Baltimore? There are plenty of volunteer opportunities available to attendees who want to maximize their involvement at the meeting.
February 29 was Rare Disease Day, providing an opportunity to raise awareness of the impact of rare diseases. Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialty pharmacies and everyone with a role in the care process.
PQA is working with its members and the broader medication therapy management (MTM) community to build consensus on the research, measurement and strategies needed to evolve our national approach to evaluating MTM service quality.
As a healthcare quality educator, PQA offers a wide range of learning and education opportunities. The goal of our education programs is to promote the use and impact of PQA measures and advance the quality of medication use through research, strategic partnerships, collaboration and a variety of learning venues.
Join us as we head back to Baltimore for the 2024 PQA Annual Meeting, May 14-16! Registration is open, so make your plans now to join us and other quality professionals at the premier event for medication use quality.
Insulin persistence is associated with positive health and economic outcomes, according to a study conducted by researchers at the University of Mississippi, the Pharmacy Quality Alliance (PQA), and Ohio Northern University, the results of which were published in Clinical Diabetes in December of 2023. The study highlights the promising applicability of a method to measure insulin persistence at the population level. This same method is the foundation for PQA’s Persistence to Basal Insulin (PST-INS) health plan performance measure.
There is tremendous momentum and a keen focus among PQA member organizations on addressing social determinants and social drivers of health (SDOH). SDOH impacts every aspect of care, including medication use, and the impact of unmet health-related social needs on patient access and use of care, outcomes, total cost of care, well-being and satisfaction is apparent and a priority to payers and providers.
PQA has released a third edition of the PQA Social Determinants of Health (SDOH) Resource Guide, which profiles 40 SDOH services, including eight new services and updates to 10 initiatives from the previous two editions.
PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. As experts in measure development, research, education and convening, they lead the implementation of PQA’s quality initiatives to support better medication use and high-quality care. This blog is one in a series profiling PQA's staff.
Save the date for the 2024 PQA Annual Meeting, May 14-16, in Baltimore, Md.
To build a larger and more diverse quality workforce, the PQA Quality Shadowing Program provides individuals from diverse groups the opportunity to observe certain nomination-based panels to gain knowledge that can support selection for future panels.
PQA has published more than 80 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2023, here’s a look back at the top five blogs of the year.
As we near the end of 2023, it’s a great time to reflect on our accomplishments this year. Certainly, each year brings its share of opportunities and challenges, and I’m proud of our progress as an alliance.
This guest blog is one in a series by sponsors of the 2023 PQA Leadership Summit on elevating clinical quality assurance. The views shared in this series are those of the author and do not reflect any PQA positions.
